Rachel Dibiasi
Nurse Practitioner · Scranton, PANPI 1831747898
Payments from drug & device makers
Across 271 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$538
- AstraZeneca$433
- AbbVie$361
- GSK$306
- Pfizer$255
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,916100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 77 | $1,347 |
| Lilly USA, LLC | 34 | $538 |
| AstraZeneca | 24 | $433 |
| AbbVie | 16 | $361 |
| GSK | 17 | $306 |
| Pfizer | 14 | $255 |
| Amgen | 11 | $210 |
| Bayer | 13 | $201 |
| Vanda Pharmaceuticals Inc. | 8 | $162 |
| Boehringer Ingelheim | 8 | $159 |
| UCB, Inc. | 6 | $134 |
| Teva Pharmaceuticals USA, Inc. | 7 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $127 |
| Daiichi Sankyo Inc. | 4 | $93 |
| Exact Sciences | 4 | $74 |
| Indivior Inc. | 3 | $65 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Shield Therapeutics Inc | 2 | $31 |
| Novartis | 1 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| Tactile Systems Technology Inc | 1 | $25 |
| Johnson & Johnson | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| VBI Vaccine (delaware) Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$127
How this compares
$4,922 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $50,563 |
| OzempicSemaglutide | 37 | $45,139 |
| XifaxanRifaximin | 13 | $41,791 |
| JardianceEmpagliflozin | 28 | $38,206 |
| FarxigaDapagliflozin Propanediol | 21 | $28,498 |
| TrulicityDulaglutide | 19 | $21,885 |
| XareltoRivaroxaban | 11 | $10,032 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $9,118 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $7,610 |
| Testosterone | 11 | $2,556 |
| Metformin Hcl ErMetformin Hcl | 37 | $1,531 |
| Potassium Chloride | 34 | $1,236 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $1,199 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $1,155 |
| Levothyroxine Sodium | 71 | $1,118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $255 | $50,56353 claims |
| Novo NordiskOzempic | $1,347 | $45,13937 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $127 | $41,79113 claims |
| Boehringer IngelheimJardiance | $159 | $38,20628 claims |
| AstraZenecaFarxiga | $433 | $28,49821 claims |
| Lilly USA, LLCTrulicity | $538 | $21,88519 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $306 | $16,72827 claims |
| Johnson & JohnsonXarelto | $20 | $10,03211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Scranton
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.